back

Elivaldogene autotemcel

Subject:

  • Active Substance: Elivaldogene autotemcel
  • Name: Skysona™
  • Therapeutic area: Cerebral Adrenoleukodystrophy (CALD)
  • Pharmaceutical company: bluebird bio, Inc.

 

Time table:

  • Publication of project plan: 26.05.2021
  • Publication of final assessment: 16.08.2021

 

Assessment information:

  • Title: Elivaldogene autotemcel (eli-cell) for treatment of Cerebral Adrenoleukodystrophy (CALD)
  • Author/Co-Author: ZIN (Netherlands), AOTMiT (Poland), GÖG (Austria)
  • Dedicated Reviewers: SNHTA (Switzerland), MIZ (Croatia)